Discovery of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amine aurora kinase inhibitors. 2010

Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
Cyclacel Ltd., 1 James Lindsay Place, Dundee DD1 5JJ, Scotland, UK.

Through cell-based screening of our kinase-directed compound collection, we discovered that a subset of N-phenyl-4-(thiazol-5-yl)pyrimidin-2-amines were potent cytotoxic agents against cancer cell lines, suppressed mitotic histone H3 phosphorylation, and caused aberrant mitotic phenotypes. It was subsequently established that these compounds were in fact potent inhibitors of aurora A and B kinases. It was shown that potency and selectivity of aurora kinase inhibition correlated with the presence of a substituent at the aniline para-position in these compounds. The anticancer effects of lead compound 4-methyl-5-(2-(4-morpholinophenylamino)pyrimidin-4-yl)thiazol-2-amine (18; K(i) values of 8.0 and 9.2 nM for aurora A and B, respectively) were shown to emanate from cell death following mitotic failure and increased polyploidy as a consequence of cellular inhibition of aurora A and B kinases. Preliminary in vivo assessment showed that compound 18 was orally bioavailable and possessed anticancer activity. Compound 18 (CYC116) is currently undergoing phase I clinical evaluation in cancer patients.

UI MeSH Term Description Entries
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000255 Adenosine Triphosphate An adenine nucleotide containing three phosphate groups esterified to the sugar moiety. In addition to its crucial roles in metabolism adenosine triphosphate is a neurotransmitter. ATP,Adenosine Triphosphate, Calcium Salt,Adenosine Triphosphate, Chromium Salt,Adenosine Triphosphate, Magnesium Salt,Adenosine Triphosphate, Manganese Salt,Adenylpyrophosphate,CaATP,CrATP,Manganese Adenosine Triphosphate,MgATP,MnATP,ATP-MgCl2,Adenosine Triphosphate, Chromium Ammonium Salt,Adenosine Triphosphate, Magnesium Chloride,Atriphos,Chromium Adenosine Triphosphate,Cr(H2O)4 ATP,Magnesium Adenosine Triphosphate,Striadyne,ATP MgCl2
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole

Related Publications

Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
October 2012, Acta crystallographica. Section E, Structure reports online,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
September 2016, ACS medicinal chemistry letters,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
June 2012, Acta crystallographica. Section E, Structure reports online,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
December 2011, Acta crystallographica. Section E, Structure reports online,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
September 2014, European journal of medicinal chemistry,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
November 2013, Acta crystallographica. Section E, Structure reports online,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
December 2012, Acta crystallographica. Section E, Structure reports online,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
September 2017, Future medicinal chemistry,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
March 2006, Bioorganic & medicinal chemistry letters,
Shudong Wang, and Carol A Midgley, and Frederic Scaërou, and Joanna B Grabarek, and Gary Griffiths, and Wayne Jackson, and George Kontopidis, and Steven J McClue, and Campbell McInnes, and Christopher Meades, and Mokdad Mezna, and Andy Plater, and Iain Stuart, and Mark P Thomas, and Gavin Wood, and Rosemary G Clarke, and David G Blake, and Daniella I Zheleva, and David P Lane, and Robert C Jackson, and David M Glover, and Peter M Fischer
October 2011, Acta crystallographica. Section E, Structure reports online,
Copied contents to your clipboard!